Anniversary of one of the largest hepatitis A outbreaks in the US brings experts together

December 13, 2004

Alexandria, VA - December 13, 2004 - As a result of hepatitis A outbreaks across the country, former United States Surgeon General, Dr. Joycelyn Elders, and the National Partnership for Immunization are joining forces to educate the public about the disease and prevention through vaccination. This initiative comes on the one-year anniversary of one of the largest hepatitis A outbreaks in U.S. history, which caused devastating health effects and severely affected families and communities near Pittsburgh, Pa. Hepatitis A is a serious and potentially deadly liver disease that may infect nearly 100,000 Americans each year. The disease, which can be prevented through vaccination, is spread via the fecal-oral route through close personal contact or the ingestion of water or food contaminated with the hepatitis A virus. Children often serve as a reservoir for hepatitis A, and unknowingly pass it on to adults.

"Many of these outbreaks, including the one in Pennsylvania, occurred in areas east of the Mississippi that do not typically have high rates of hepatitis A," said Elders. "If you take a closer look at the 17 states where routine hepatitis A vaccination should be implemented or considered, you'll see what an impact the vaccination has had on lowering the number of cases of the disease. It's time for health officials to consider hepatitis A vaccination for all children at potential risk in order to protect them, their families and their communities."

Despite the availability of effective vaccines, hepatitis A remains one of the most commonly reported vaccine-preventable diseases in the country. Current immunization policies are limited to children in states with high incidence rates. However, these states account for only half of all reported cases of hepatitis A in the country, leaving many at risk for contracting the disease.

Devastating Outbreaks that Could be Prevented

One year ago, the hepatitis A outbreak near Pittsburgh affected approximately 600 people, who contracted the disease from contaminated food at a local restaurant. Not only was this one of the largest outbreaks of hepatitis A in U.S. history, but it also resulted in the deaths of three people.

"Hepatitis A is a serious and continuing public health threat," said David Neumann, PhD, Executive Director of the National Partnership for Immunization. "Recent outbreaks have had an enormous impact on communities, causing illness and even death. Unfortunately, many of these cases could have been prevented through vaccination."

Hepatitis A can affect anyone, as evidenced by the recent outbreaks in areas across the country. According to the Advisory Committee on Immunization Practices of the Centers for Disease Control and Prevention, routine vaccination of children is the most effective way to reduce hepatitis A incidence nationwide over time. Research shows that national childhood vaccination of hepatitis A would reduce the number of primary cases by 54 percent and would be a cost-effective strategy. Hepatitis A is a potentially fatal liver disease which significantly impacts the U.S. economy, costing nearly $500 million annually.

Expanding childhood vaccination requirements could be an effective strategy to help save lives, reduce the burden of hepatitis A disease and reduce this negative impact on the economy. For more information on hepatitis A and prevention through vaccination, log on to Support for this educational effort is being provided by GlaxoSmithKline, a company that joins NPI in its commitment to help reduce the incidence of hepatitis A in the U.S.
About Hepatitis A
Hepatitis A is a serious liver disease caused by the hepatitis A virus. This virus is found in the stool of persons with hepatitis A and is spread by close personal contact and by eating food or drinking water contaminated with the hepatitis A virus. Hepatitis A can be easily passed by those infected with the disease to others within the same household. Children are among the highest risk groups for hepatitis A because they often come in close contact with other children in child care and school settings.

About one in five people with the disease have to be hospitalized and up to 100 people with the disease may die each year. Symptoms of the disease can be debilitating and include fever, fatigue, loss of appetite, nausea, abdominal discomfort, jaundice and dark urine.

About the National Partnership for Immunization
The National Partnership for Immunization (NPI) is a non-profit organization that was created in 2000 to encourage greater awareness, acceptance and use of immunization by people of all ages through partnerships with public and private organizations. NPI brings together private and public sector partners, including healthcare provider professional associations, community-based organizations, policymakers, vaccine manufacturers, insurance companies, managed care corporations, hospitals, major employers, healthcare and social service professionals, medical and scientific researchers and public health advocates to improve the effectiveness of public and professional educational and outreach efforts to reduce the incidence of vaccine-preventable diseases among children, adolescents and adults.

Cohn & Wolfe

Related Hepatitis Articles from Brightsurf:

Busting Up the Infection Cycle of Hepatitis B
Researchers at the University of Delaware have gained new understanding of the virus that causes hepatitis B and the ''spiky ball'' that encloses its genetic blueprint.

Liver cancer: Awareness of hepatitis D must be raised
Scientists from the University of Geneva (UNIGE) and the Geneva University Hospitals (HUG) have studied the most serious consequence of chronic hepatitis: hepatocellular carcinoma.

Hepatitis B: New therapeutic approach may help to cure chronic hepatitis B infection
Researchers at Helmholtz Zentrum München, Technical University of Munich (TUM) and the German Center for Infection Research (DZIF) have developed a novel therapeutic approach to cure chronic hepatitis B.

Anti-hepatitis medicine surprises
A new effective treatment of hepatitis C not only combats the virus, but is also effective against potentially fatal complications such as reduced liver functioning and cirrhosis.

Nanotechnology delivers hepatitis B vaccine
X-ray imaging shows that nanostructured silica acts as a protective vehicle to deliver intact antigen to the intestine so that it can trigger an immune response.

Checkmate for hepatitis B viruses in the liver
Researchers at Helmholtz Zentrum München and the Technical University of Munich, working in collaboration with researchers at the University Medical Center Hamburg-Eppendorf and the University Hospital Heidelberg, have for the first time succeeded in conquering a chronic infection with the hepatitis B virus in a mouse model.

How common is Hepatitis C infection in each US state?
Hepatitis C virus infection is a major cause of illness and death in the United States and injection drug use is likely fueling many new cases.

New strains of hepatitis C found in Africa
The largest population study of hepatitis C in Africa has found three new strains of the virus circulating in the general population in sub-Saharan Africa.

High stability of the hepatitis B virus
At room temperature, hepatitis B viruses (HBV) remain contagious for several weeks and they are even able to withstand temperatures of four degrees centigrade over the span of nine months.

Findings could lead to treatment of hepatitis B
Researchers have gained new insights into the virus that causes hepatitis B -- a life-threatening and incurable infection that afflicts more than 250 million people worldwide.

Read More: Hepatitis News and Hepatitis Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to